-
First-trimester screening for trisomies in pregnancies with vanishing twin.
Chaveeva P, Wright A, Syngelaki A, Konstantinidou L, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;55:326-331. pdf -
Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
Galeva S, Konstantinidou L, Gil MM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;53:208-213. pdf -
Impact of holoprosencephaly, exomphalos, megacystis and increased nuchal translucency on first-trimester screening for chromosomal abnormalities.
Syngelaki A, Guerra L, Ceccacci I, Efeturk T, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:45-48. pdf -
Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies.
Gil MM, Quezada MS, Bregant B, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2014;35:204-11. pdf -
Clinical significance of first-trimester chorionic bumps: a matched case-control study.
Sana Y, Appiah A, Davison A, Nicolaides KH, Johns J, Ross JA.
Ultrasound Obstet Gynecol 2013;42:585-9. -
Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model.
Wright D, Syngelaki A, Staboulidou I, Cruz JJ, Nicolaides KH.
Prenat Diagn 2011;31:16-21. -
First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers.
Spencer K, Staboulidou I, Nicolaides KH.
Prenat Diagn 2010;30:235-40. -
The 11-13-week scan: diagnosis and outcome of holoprosencephaly, exomphalos and megacystis.
Kagan KO, Staboulidou I, Syngelaki A, Cruz JJ, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;36:10-4. -
Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH.
Obstet Gynecol 2008;112:598-605. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Dilemmas in the management of twins discordant for anencephaly diagnosed at 11 + 0 to 13 + 6 weeks of gestation.
Vandecruys H, Avgidou K, Surerus E, Flack N, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;28:653-8. -
First-trimester maternal serum PAPP-A, SP1 and M-CSF levels in normal and trisomic twin pregnancies.
Bersinger NA, Noble P, Nicolaides KH.
Prenat Diagn 2003;23:157-62. -
Distribution of fetal erythroblasts enriched from maternal blood in multifetal pregnancies.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
Hum Reprod 2003;18:1933-6. -
The 11-14 week scan.
Nicolaides KH, Heath V, Liao AW.
Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:581-94. -
Cardiac expression of sarcoplasmic reticulum calcium ATPase in fetuses with trisomy 21 and trisomy 18 presenting with nuchal translucency.
von Kaisenberg CS, Huggon I, Hyett JA, Farzaneh F, Nicolaides KH.
Fetal Diagn Ther 1997:12:270-3. -
Management of twin pregnancies with fetal trisomies.
Sebire NJ, Snijders RJM, Santiago C, Papapanagiotou G, Nicolaides KH.
BJOG 1997;104:220-2. -
Maternal serum free beta-hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies.
Noble PL, Snijders RJ, Abraha HD, Sherwood RA, Nicolaides KH.
BJOG 1997;104:741-3. -
Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses.
Hyett J, Moscoso G, Nicolaides KH.
Am J Med Genet 1997;69:207-16. -
Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency.
Sebire NJ, Noble PL, Psarra A, Papapanagiotou G, Nicolaides KH.
BJOG 1996;103:887-90. -
Case report: uniparental disomy 16 in association with congenital heart disease.
O'Riordan S, Greenough A, Moore GE, Bennett P, Nicolaides KH.
Prenat Diagn 1996;16:963-5.